Immunofluorescence Quantitative Detection Series

A comprehensive series of diagnostic tests for the detection of various infectious diseases. These products enable rapid identification of pathogenic infections.

A series of diagnostic tests for the detection of inflammatory markers and biomarkers. These products enable rapid identification of inflammatory conditions.

A POCT-series rapid quantitative immunodetection system designed for point-of-care testing applications. The system uses immunofluorescence lateral flow detection methodology and can process whole blood, serum, or plasma samples. It offers a detection throughput of 80 tests per hour with precision (CV) less than 3%, and is capable of detecting multiple analytes including C-reactive protein, procalcitonin, cardiac troponin I, CK-MB, myoglobin, D-dimer, NT-proBNP, serum amyloid A, and influenza A and B.

Quantitative immunofluorescence-based rapid test for precise measurement of analytes in clinical specimens. Combines fluorescence detection with rapid testing methodology for accurate results. Suitable for various immunological assessments in diagnostic laboratories.

Immunofluorescence-based test kits utilizing quantum dot technology for enhanced sensitivity and photostability. Provide qualitative and quantitative detection of various analytes in clinical samples.

Fluorescence-based diagnostic assay for sensitive detection of biomarkers and pathogens in clinical samples.

Immunofluorescence diagnostic testing services utilizing fluorescent antibodies for the detection and identification of pathogens and disease markers. The technology is applied across clinical departments for rapid pathogen identification.

Immunofluorescence-based diagnostic platform for detection and identification of specific antigens or antibodies in clinical samples. Provides fluorescence-based results for rapid point-of-care and laboratory testing.

Advanced assay for detecting biomarkers associated with infectious diseases. Enables rapid diagnostic testing in point-of-care settings.

Immunofluorescence assays for precise detection and diagnosis of tumors, infectious diseases, chronic conditions, and genetic disorders. These fluorescent-based diagnostic tests enable cancer screening, disease diagnosis, and treatment monitoring across clinical and laboratory settings.

Chromatography-based immunofluorescence test format for qualitative and semi-quantitative pathogen detection. Applicable to infectious disease screening.

Fluorescently-labeled antibody kits for detecting specific antigens in clinical samples. Used in microbiology and immunopathology for identification of infectious agents and diseased tissues.